Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study

Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...

Full description

Saved in:
Bibliographic Details
Published inJournal of Clinical Microbiology Vol. 46; no. 9; pp. 2902 - 2905
Main Authors GONZALEZ, Gloria M, ELIZONDO, Mariana, AYALA, Jacobo
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.09.2008
American Society for Microbiology (ASM)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JCM RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0095-1137 Online ISSN: 1098-660X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JCM .asm.org, visit: JCM       
AbstractList ABSTRACT During a 3-year surveillance program (2004 to 2007) in Monterrey, Mexico, 398 isolates of Candida spp. were collected from five hospitals. We established the species distribution and in vitro susceptibilities of these isolates. The species included 127 Candida albicans strains, 151 C . parapsilosis strains, 59 C . tropicalis strains, 32 C . glabrata strains, 11 C . krusei strains, 5 C . guilliermondii strains, 4 C . famata strains, 2 C . utilis strains, 2 C . zeylanoides strains, 2 C . rugosa strains, 2 C . lusitaniae strains, and 1 C . boidinii strain. The species distribution differed with the age of the patients. The proportion of candidemias caused by C . parapsilosis was higher among infants ≤1 year old, and the proportion of candidemias caused by C . glabrata increased with patient age (>45 years old). MICs were calculated following the criteria of the Clinical Laboratory Standards Institute reference broth macrodilution method. Overall, C . albicans , C . parapsilosis , and C . tropicalis isolates were susceptible to fluconazole and amphotericin B. However, 31.3% of C . glabrata isolates were resistant to fluconazole (MIC ≥ 64 μg/ml), 43.3% were resistant to itraconazole (MIC ≥ 1 μg/ml), and 12.5% displayed resistance to amphotericin B (MIC ≥ 2 μg/ml). Newer triazoles, namely, voriconazole, posaconazole, and ravuconazole, had a notable in vitro activity against all Candida species tested. Also, caspofungin was active against Candida sp. isolates (MIC 90 ≤ 0.5 μg/ml) except C . parapsilosis (MIC 90 = 2 μg/ml). It is imperative to promote a national-level surveillance program to monitor this important microorganism.
During a 3-year surveillance program (2004 to 2007) in Monterrey, Mexico, 398 isolates of Candida spp. were collected from five hospitals. We established the species distribution and in vitro susceptibilities of these isolates. The species included 127 Candida albicans strains, 151 C . parapsilosis strains, 59 C . tropicalis strains, 32 C . glabrata strains, 11 C . krusei strains, 5 C . guilliermondii strains, 4 C . famata strains, 2 C . utilis strains, 2 C . zeylanoides strains, 2 C . rugosa strains, 2 C . lusitaniae strains, and 1 C . boidinii strain. The species distribution differed with the age of the patients. The proportion of candidemias caused by C . parapsilosis was higher among infants ≤1 year old, and the proportion of candidemias caused by C . glabrata increased with patient age (>45 years old). MICs were calculated following the criteria of the Clinical Laboratory Standards Institute reference broth macrodilution method. Overall, C . albicans , C . parapsilosis , and C . tropicalis isolates were susceptible to fluconazole and amphotericin B. However, 31.3% of C . glabrata isolates were resistant to fluconazole (MIC ≥ 64 μg/ml), 43.3% were resistant to itraconazole (MIC ≥ 1 μg/ml), and 12.5% displayed resistance to amphotericin B (MIC ≥ 2 μg/ml). Newer triazoles, namely, voriconazole, posaconazole, and ravuconazole, had a notable in vitro activity against all Candida species tested. Also, caspofungin was active against Candida sp. isolates (MIC 90 ≤ 0.5 μg/ml) except C . parapsilosis (MIC 90 = 2 μg/ml). It is imperative to promote a national-level surveillance program to monitor this important microorganism.
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JCM RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0095-1137 Online ISSN: 1098-660X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JCM .asm.org, visit: JCM       
During a 3-year surveillance program (2004 to 2007) in Monterrey, Mexico, 398 isolates of Candida spp. were collected from five hospitals. We established the species distribution and in vitro susceptibilities of these isolates. The species included 127 Candida albicans strains, 151 C. parapsilosis strains, 59 C. tropicalis strains, 32 C. glabrata strains, 11 C. krusei strains, 5 C. guilliermondii strains, 4 C. famata strains, 2 C. utilis strains, 2 C. zeylanoides strains, 2 C. rugosa strains, 2 C. lusitaniae strains, and 1 C. boidinii strain. The species distribution differed with the age of the patients. The proportion of candidemias caused by C. parapsilosis was higher among infants <or=1 year old, and the proportion of candidemias caused by C. glabrata increased with patient age (>45 years old). MICs were calculated following the criteria of the Clinical Laboratory Standards Institute reference broth macrodilution method. Overall, C. albicans, C. parapsilosis, and C. tropicalis isolates were susceptible to fluconazole and amphotericin B. However, 31.3% of C. glabrata isolates were resistant to fluconazole (MIC >or= 64 microg/ml), 43.3% were resistant to itraconazole (MIC >or= 1 microg/ml), and 12.5% displayed resistance to amphotericin B (MIC >or= 2 microg/ml). Newer triazoles, namely, voriconazole, posaconazole, and ravuconazole, had a notable in vitro activity against all Candida species tested. Also, caspofungin was active against Candida sp. isolates (MIC(90) <or= 0.5 microg/ml) except C. parapsilosis (MIC(90) = 2 microg/ml). It is imperative to promote a national-level surveillance program to monitor this important microorganism.
Author Jacobo Ayala
Gloria M. González
Mariana Elizondo
AuthorAffiliation Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, 1 Unidad de Vigilancia Epidemiológica, Hospital San José-Tec. de Monterrey, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico 2
AuthorAffiliation_xml – name: Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, 1 Unidad de Vigilancia Epidemiológica, Hospital San José-Tec. de Monterrey, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico 2
Author_xml – sequence: 1
  givenname: Gloria M
  surname: GONZALEZ
  fullname: GONZALEZ, Gloria M
  organization: Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Mexico
– sequence: 2
  givenname: Mariana
  surname: ELIZONDO
  fullname: ELIZONDO, Mariana
  organization: Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Mexico
– sequence: 3
  givenname: Jacobo
  surname: AYALA
  fullname: AYALA, Jacobo
  organization: Unidad de Vigilancia Epidemiológica, Hospital San José-Tec. de Monterrey, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Mexico
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20637383$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18632907$$D View this record in MEDLINE/PubMed
BookMark eNpVkU2P0zAQhiO0iP2AG2dkDotAahY7ThyHA1IpX4u2QqKLBCfLcSatV45dbKfQP8jvwt1WC5xGGj_z-p15T7Mj6yxk2WOCLwgp-MtPs_kFxg2tc8zvZScENzxnDH87yk5Su8oJofVxdhrCDcakLKvqQXZMOKNFg-uT7Pe1B9sFpC1arEFpCOitDtHrdozaWSRthxZjULCOutVGxy1yPXpjnOsSBXJAl8EZGdNc6s8SrjuJZs4YUBG6ne7c2Qjew3aC5vBLKzdB0aEFbMCiqY26H-1SGjRdgo3hFfoCYTTxVk4imn8H6dHzAuNyN5Vq_SIZ8hvQxkirAC3i2G0fZvd7aQI8OtSz7Ov7d9ezj_nV5w-Xs-lVrkrKY97SlkPbNr3q2qLgLfC6wV0jFesqLonkXY9VxUjZQ89wC7WUWBFWgqwJVFTSs-z1Xnc9tgN0Kln20oi114P0W-GkFv-_WL0SS7cRRVWymhZJ4NlBwLsfI4QoBp2uu9sF3BgEaypS1QVL4GQPKu9C8NDffUKw2AUvUvDiNniBecKf_GvsL3xIOgHnB0AGJU3v0_F0uOMKzGhNOU3c0z230svVT-1ByDCIGzWIkolGJK2C_gH2O8aC
CODEN JCMIDW
CitedBy_id crossref_primary_10_1128_JCM_00490_12
crossref_primary_10_2217_fmb_13_147
crossref_primary_10_4236_ojst_2019_912030
crossref_primary_10_1007_s12281_011_0081_7
crossref_primary_10_1016_j_riam_2017_05_001
crossref_primary_10_3390_jof10050304
crossref_primary_10_1007_s10534_015_9825_0
crossref_primary_10_1093_mmy_myt019
crossref_primary_10_1007_s11046_021_00592_8
crossref_primary_10_1016_j_peptides_2010_10_022
crossref_primary_10_2147_IDR_S368792
crossref_primary_10_1016_j_diagmicrobio_2010_01_002
crossref_primary_10_3390_molecules26195760
crossref_primary_10_3109_13693786_2012_712724
crossref_primary_10_1016_j_ijantimicag_2013_09_005
crossref_primary_10_1093_mmy_myw126
crossref_primary_10_1128_JCM_02117_09
crossref_primary_10_1099_jmm_0_075507_0
crossref_primary_10_1016_j_indcrop_2012_03_038
crossref_primary_10_3109_13693786_2010_503195
crossref_primary_10_5812_jjm_69782
crossref_primary_10_1111_cbdd_12625
crossref_primary_10_1128_JCM_02035_09
crossref_primary_10_3390_jof3020024
crossref_primary_10_1128_JCM_00946_09
crossref_primary_10_1586_eri_10_2
crossref_primary_10_1111_j_1574_6976_2011_00278_x
crossref_primary_10_3109_00365548_2014_900190
crossref_primary_10_3390_clinpract14020031
crossref_primary_10_1111_j_1469_0691_2010_03248_x
crossref_primary_10_1007_s15010_019_01275_9
crossref_primary_10_2478_bjdm_2019_0027
crossref_primary_10_1016_j_riam_2022_12_002
crossref_primary_10_1371_journal_pone_0097325
crossref_primary_10_3390_ijms20040988
crossref_primary_10_1016_j_riam_2013_10_001
crossref_primary_10_2217_fmb_2015_0016
crossref_primary_10_1128_AAC_00966_12
crossref_primary_10_3314_mmj_16_00006
crossref_primary_10_2478_bjdm_2018_0003
crossref_primary_10_1016_j_riam_2017_01_005
crossref_primary_10_3109_13693786_2012_675526
crossref_primary_10_1080_00275514_2019_1585161
crossref_primary_10_1017_S0950268819001638
crossref_primary_10_1128_AAC_00479_10
crossref_primary_10_1590_S0074_02762009000500019
crossref_primary_10_1016_j_riam_2010_11_003
crossref_primary_10_1016_j_diagmicrobio_2008_11_001
crossref_primary_10_1016_j_riam_2010_11_004
crossref_primary_10_4236_ojmm_2013_34036
crossref_primary_10_1086_653616
crossref_primary_10_1007_s11046_011_9459_x
crossref_primary_10_1016_j_clindermatol_2009_12_006
crossref_primary_10_1007_s11046_011_9431_9
crossref_primary_10_1111_j_1600_0757_2009_00338_x
crossref_primary_10_1007_s11046_011_9413_y
crossref_primary_10_1371_journal_pone_0210527
crossref_primary_10_1111_j_1472_765X_2010_02907_x
crossref_primary_10_1586_eri_10_163
crossref_primary_10_2165_00148581_200911040_00005
crossref_primary_10_1128_AAC_00651_13
crossref_primary_10_1007_s12519_016_0034_x
crossref_primary_10_1111_j_1439_0507_2011_02165_x
crossref_primary_10_1007_s42399_022_01148_7
crossref_primary_10_1016_j_ram_2016_12_011
crossref_primary_10_1093_jac_dkt283
crossref_primary_10_1007_s42770_022_00813_2
crossref_primary_10_4103_ijmm_IJMM_17_102
crossref_primary_10_1007_s12281_010_0033_7
crossref_primary_10_1111_1469_0691_12440
crossref_primary_10_3390_pathogens6040062
crossref_primary_10_4103_0255_0857_158569
crossref_primary_10_4236_ojmm_2016_62010
crossref_primary_10_1517_14728214_2011_607811
crossref_primary_10_4236_ojmm_2013_34040
crossref_primary_10_2174_0929867325666180601102333
crossref_primary_10_1002_wsbm_1641
crossref_primary_10_1586_eri_12_74
crossref_primary_10_1016_j_archoralbio_2015_03_002
crossref_primary_10_1179_joc_2010_22_1_68
crossref_primary_10_1556_amicr_59_2012_1_4
Cites_doi 10.1111/j.1470-9465.2004.t01-1-00844.x
10.1016/S0732-8893(97)00240-X
10.1128/JCM.41.5.2176-2179.2003
10.1086/342300
10.1086/520192
10.1128/JCM.42.7.3117-3119.2004
10.1128/AAC.42.4.734
10.1086/520277
10.1086/315193
10.1016/S0732-8893(98)00160-6
10.1086/378745
10.1016/S0002-9343(95)00010-0
10.1086/514193
10.1128/JCM.00029-06
10.1093/clinids/20.1.115
10.1128/JCM.40.4.1298-1302.2002
10.1016/S0732-8893(97)00192-2
10.1086/321811
10.1128/JCM.36.7.1886-1889.1998
10.1128/JCM.44.3.819-826.2006
10.1128/JCM.42.4.1519-1527.2004
10.1086/502452
10.1128/JCM.40.10.3551-3557.2002
10.1086/520194
10.1086/513663
10.1128/JCM.37.3.531-537.1999
10.1001/archinte.1988.00380120094019
10.1093/jac/dki258
10.1128/JCM.00773-06
ContentType Journal Article
Copyright 2008 INIST-CNRS
Copyright © 2008, American Society for Microbiology
Copyright_xml – notice: 2008 INIST-CNRS
– notice: Copyright © 2008, American Society for Microbiology
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1128/JCM.00937-08
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-660X
EndPage 2905
ExternalDocumentID 10_1128_JCM_00937_08
18632907
20637383
jcm_46_9_2902
Genre Journal Article
GeographicLocations Central America
Mexico
America
GroupedDBID ---
.55
.GJ
08R
0R~
18M
29K
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
AAUGY
AAYOK
ABOCM
ABPPZ
ACGFO
ADBBV
AENEX
AFMIJ
AGCDD
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HF~
HYE
HZ~
H~9
IQODW
KQ8
L7B
O9-
OHT
OK1
P2P
P6G
RHF
RHI
RNS
RPM
RSF
TR2
UCJ
VH1
W8F
WHG
WOQ
X7M
ZA5
ZCA
ZGI
ZXP
~KM
AGVNZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c438t-b3b8ebb9fcdb228be8790d9ac6d58a1a8df0c5614fef60be7aa0c164ea71e53a3
IEDL.DBID RPM
ISSN 0095-1137
IngestDate Tue Sep 17 21:23:03 EDT 2024
Fri Aug 16 05:02:12 EDT 2024
Thu Sep 12 17:00:21 EDT 2024
Sat Sep 28 08:37:29 EDT 2024
Sun Oct 22 16:07:46 EDT 2023
Wed May 18 15:27:45 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Fungi
Infection
Antifungal agent
Candidiasis
Sensitivity
Yeast
Mycosis
Microbiology
Candida
Isolate
Fungi Imperfecti
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c438t-b3b8ebb9fcdb228be8790d9ac6d58a1a8df0c5614fef60be7aa0c164ea71e53a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Facultad de Medicina, Universidad Autónoma de Nuevo León, Departamento de Microbiología, Madero y Dr. Eduardo A. Pequeño s/n, Colonia Mitras Centro, Monterrey, NL, México 64460. Phone: (5281) 8329 4166. Fax: (5281) 8348 5477. E-mail: gmglez@yahoo.com.mx
OpenAccessLink https://doi.org/10.1128/jcm.00937-08
PMID 18632907
PQID 69515726
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_69515726
crossref_primary_10_1128_JCM_00937_08
highwire_asm_jcm_46_9_2902
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2546732
pascalfrancis_primary_20637383
pubmed_primary_18632907
PublicationCentury 2000
PublicationDate 2008-09-01
PublicationDateYYYYMMDD 2008-09-01
PublicationDate_xml – month: 09
  year: 2008
  text: 2008-09-01
  day: 01
PublicationDecade 2000
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Journal of Clinical Microbiology
PublicationTitleAlternate J Clin Microbiol
PublicationYear 2008
Publisher American Society for Microbiology
American Society for Microbiology (ASM)
Publisher_xml – name: American Society for Microbiology
– name: American Society for Microbiology (ASM)
References 10608780 - J Infect Dis. 2000 Jan;181(1):309-16
15243069 - J Clin Microbiol. 2004 Jul;42(7):3117-9
16517860 - J Clin Microbiol. 2006 Mar;44(3):819-26
9650930 - J Clin Microbiol. 1998 Jul;36(7):1886-9
3196127 - Arch Intern Med. 1988 Dec;148(12):2642-5
7727637 - Clin Infect Dis. 1995 Jan;20(1):115-25
10476721 - Clin Infect Dis. 1999 Aug;29(2):253-8
14748799 - Clin Microbiol Infect. 2004 Mar;10 Suppl 1:11-23
14557960 - Clin Infect Dis. 2003 Nov 1;37(9):1172-7
9597393 - Diagn Microbiol Infect Dis. 1998 May;31(1):327-32
16757587 - J Clin Microbiol. 2006 Jun;44(6):1977-81
11418877 - Clin Infect Dis. 2001 Jul 15;33(2):177-86
15070998 - J Clin Microbiol. 2004 Apr;42(4):1519-27
16040623 - J Antimicrob Chemother. 2005 Sep;56(3):532-7
9986807 - J Clin Microbiol. 1999 Mar;37(3):531-7
12354845 - J Clin Microbiol. 2002 Oct;40(10):3551-7
8678081 - Am J Med. 1996 Jun;100(6):617-23
10476719 - Clin Infect Dis. 1999 Aug;29(2):239-44
16891497 - J Clin Microbiol. 2006 Aug;44(8):2816-23
9559774 - Antimicrob Agents Chemother. 1998 Apr;42(4):734-8
11923348 - J Clin Microbiol. 2002 Apr;40(4):1298-302
15357152 - Infect Control Hosp Epidemiol. 2004 Aug;25(8):628-33
9597232 - Clin Infect Dis. 1998 May;26(5):1086-8
9195068 - Clin Infect Dis. 1997 Jun;24(6):1122-8
9466531 - J Infect Dis. 1998 Feb;177(2):425-30
12734273 - J Clin Microbiol. 2003 May;41(5):2176-9
9554180 - Diagn Microbiol Infect Dis. 1998 Feb;30(2):121-9
10212747 - Diagn Microbiol Infect Dis. 1999 Apr;33(4):217-22
12173140 - Clin Infect Dis. 2002 Sep 1;35(5):627-30
e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_2_2
e_1_3_2_14_2
References_xml – ident: e_1_3_2_23_2
  doi: 10.1111/j.1470-9465.2004.t01-1-00844.x
– ident: e_1_3_2_18_2
  doi: 10.1016/S0732-8893(97)00240-X
– ident: e_1_3_2_22_2
  doi: 10.1128/JCM.41.5.2176-2179.2003
– ident: e_1_3_2_29_2
  doi: 10.1086/342300
– ident: e_1_3_2_8_2
  doi: 10.1086/520192
– ident: e_1_3_2_24_2
  doi: 10.1128/JCM.42.7.3117-3119.2004
– ident: e_1_3_2_5_2
  doi: 10.1128/AAC.42.4.734
– ident: e_1_3_2_12_2
  doi: 10.1086/520277
– ident: e_1_3_2_13_2
  doi: 10.1086/315193
– ident: e_1_3_2_20_2
  doi: 10.1016/S0732-8893(98)00160-6
– ident: e_1_3_2_9_2
  doi: 10.1086/378745
– ident: e_1_3_2_15_2
  doi: 10.1016/S0002-9343(95)00010-0
– ident: e_1_3_2_16_2
  doi: 10.1086/514193
– ident: e_1_3_2_28_2
  doi: 10.1128/JCM.00029-06
– ident: e_1_3_2_31_2
  doi: 10.1093/clinids/20.1.115
– ident: e_1_3_2_7_2
  doi: 10.1128/JCM.40.4.1298-1302.2002
– ident: e_1_3_2_19_2
  doi: 10.1016/S0732-8893(97)00192-2
– ident: e_1_3_2_14_2
– ident: e_1_3_2_4_2
  doi: 10.1086/321811
– ident: e_1_3_2_17_2
  doi: 10.1128/JCM.36.7.1886-1889.1998
– ident: e_1_3_2_25_2
  doi: 10.1128/JCM.44.3.819-826.2006
– ident: e_1_3_2_10_2
  doi: 10.1128/JCM.42.4.1519-1527.2004
– ident: e_1_3_2_26_2
  doi: 10.1086/502452
– ident: e_1_3_2_21_2
  doi: 10.1128/JCM.40.10.3551-3557.2002
– ident: e_1_3_2_27_2
  doi: 10.1086/520194
– ident: e_1_3_2_2_2
  doi: 10.1086/513663
– ident: e_1_3_2_3_2
  doi: 10.1128/JCM.37.3.531-537.1999
– ident: e_1_3_2_30_2
  doi: 10.1001/archinte.1988.00380120094019
– ident: e_1_3_2_11_2
  doi: 10.1093/jac/dki258
– ident: e_1_3_2_6_2
  doi: 10.1128/JCM.00773-06
SSID ssj0014455
Score 2.333577
Snippet Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...
During a 3-year surveillance program (2004 to 2007) in Monterrey, Mexico, 398 isolates of Candida spp. were collected from five hospitals. We established the...
ABSTRACT During a 3-year surveillance program (2004 to 2007) in Monterrey, Mexico, 398 isolates of Candida spp. were collected from five hospitals. We...
During a 3-year surveillance program (2004 to 2007) in Monterrey, Mexico, 398 isolates of Candida spp. were collected from five hospitals. We established the...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2902
SubjectTerms Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Amphotericin B - pharmacology
Amphotericin B - therapeutic use
Antifungal Agents - pharmacology
Antifungal Agents - therapeutic use
Biological and medical sciences
Candida - drug effects
Candida albicans - drug effects
Candida glabrata - drug effects
Candida tropicalis - drug effects
Candidiasis - drug therapy
Candidiasis - microbiology
Caspofungin
Child
Child, Preschool
Echinocandins - pharmacology
Echinocandins - therapeutic use
Female
Fluconazole - pharmacology
Fluconazole - therapeutic use
Fundamental and applied biological sciences. Psychology
Humans
Infant
Infant, Newborn
Itraconazole - pharmacology
Itraconazole - therapeutic use
Lipopeptides
Male
Mexico
Microbial Sensitivity Tests
Microbiology
Middle Aged
Miscellaneous
Mycology
Pyrimidines - pharmacology
Pyrimidines - therapeutic use
Thiazoles - pharmacology
Thiazoles - therapeutic use
Triazoles - pharmacology
Triazoles - therapeutic use
Voriconazole
Young Adult
Title Trends in Species Distribution and Susceptibility of Bloodstream Isolates of Candida Collected in Monterrey, Mexico, to Seven Antifungal Agents: Results of a 3-Year (2004 to 2007) Surveillance Study
URI http://jcm.asm.org/content/46/9/2902.abstract
https://www.ncbi.nlm.nih.gov/pubmed/18632907
https://search.proquest.com/docview/69515726
https://pubmed.ncbi.nlm.nih.gov/PMC2546732
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXaSiAuCMpHU6D4ABJIzW5ix7HNrSxUpVIQolQqJ8t2HLGoyVabLGL_IL8Lj5OULuLEdbOxrMybeCbzZh5CL1LJpcuhZlimIs6cT1D8Oc7iyhJuqTGMEWhOLj7mJ-fZ6QW72EJs7IUJpH1r5pPmsp4082-BW3lV2-nIE5t-KmYww51TMt1G25zSMUUfSgdZxnrZAsniNKV8ZLsTMT2dFRNI4XmcBJ0-kVMiQUj25pE0jgkGlqRu_YOqeoWLf4WgfzMpbxxNx_fQ3SGmxEf93u-jLdfsolu9yuR6F90uhvr5A_Srp8DieYOD8Lxr8TuYnDuIXmHdlPhs1QaqS2DNrvGiwm-B3A5NJbrGHzxWITyF32fQElNqHD4-WB-6wroFjLtaeoAc4sL99Dg7xN0Cn8GgKHwEzCT_doHNQktX-wZ_du3qsgvLaUzjr97x8CvwKbgLvnC-9hta_nAgjuTxiYH3uH6Izo_ff5mdxIOSQ2wzKrrYUCOcMbKypSFEGCe4TEqpbV4yoVMtyiqxMJO0clWeGMe1TqxP5JzmqWNU00dop1k0bg9hKTWpSkmI0SCWLQ1nJsmFhQJ65QSJ0MvRmOqqH9ihQqJDhPL2V8H-KhER2h8trXRbq--2VlmupPKI8IscbNj-eiXiIzruk_oIPR_BoLw_QpFFN26xalUOUOckj9DjHhp_djHALUJ8AzTXf4BJ35tXvAOEid8D4Pf_-84n6M5IdEnSp2inW67cMx9NdeYgeM9vW_4f8A
link.rule.ids 230,315,733,786,790,891,27955,27956,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGEJcXLuPWAZsfQAJpaRM7iW3eRmHqxjIhdtF4smzHEYU1nZoUUX4gvwsfJxnrxAu8No3lVN-pz8n5zvch9CISTNgUeoZ5xIPYugLFneNJUBjCDNU6SQgMJ2cH6eg43jtNTldQ0s3CeNK-0eN-eTbpl-Mvnlt5PjGDjic2-JgNQcOdUTK4hq67eCVJV6S3zYM4ThrjApEEUURZx3cnfLA3zPpQxLMg9E59PKVEgJXs5UOpEwoGnqSq3E9VNB4Xf0tCr3IpLx1OO3fRSfdYDSflW39e6775eUXx8Z-f-x6606areLu5fB-t2HIN3WgMLBdr6GbWtuYfoF8NuxaPS-w97W2F34Eob-unhVWZ48N55Vk0npC7wNMCvwXePMyrqAnedWEAmS98PoRpm1xh_17DuKwY1s1ASWvmsLeFM_vDQXgL11N8CBpUeBtIT-6PCzYL02LVG_zJVvOz2i-nMA0-u5jGryBc4S54efrabWj23YLvkoM-Bkrl4iE63nl_NBwFrUlEYGLK60BTza3WojC5JoRry5kIc6FMmidcRYrnRWhA7rSwRRpqy5QKjasRrWKRTaiij9BqOS3tE4SFUKTIBSFagQ-30CzRYcoN9OYLy0kPvexQIs8bLRDpayjCpQOW9MCSIe-h9Q5CUlUT-dVMZJxKIR3U3CIbS6C6WIm4ZJFRTntos0OZdKEO_RtV2um8kilEESNpDz1uMPdnFy2Oe4gtofHiCyAivnzFYcyLibeYWv_vOzfRrdFRti_3dw8-PEW3Oz5NGD1Dq_Vsbp-7pK3WGz5EfwP3_0Hj
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVgiIkXPsZXB2x-AAmkpU3sJLZ5Gx3VNsg0MSYNXizbcURhTasmRZQfyO_C10lGN_G013xYTnRufG_u8TkIvYwEEzaFnmEe8SC2rkBx63gSFIYwQ7VOEgKbk7OjdP80PjxLzlasvjxp3-hxvzyf9MvxN8-tnE3MoOOJDY6zIWi4M0oGs7wY3ES3XMwS1hXqbQMhjpPGvEAkQRRR1nHeCR8cDrM-FPIsCL1bH08pEWAnu7owdWLBwJVUlXtdReNz8b9E9CqfcmWBGt1DX7tHa3gpP_qLWvfN7yuqj9d69vvobpu24t3mkgfohi030O3GyHK5gdaztkX_EP1pWLZ4XGLvbW8rvAfivK2vFlZljk8WlWfTeGLuEk8L_A7487BvRU3wgQsHyIDh-BB23eQK-_8bxmXHMG4Gilpzh8EdnNlfDso7uJ7iE9CiwrtAfnIfMJgs7Bqr3uJPtlqc1344hWnwxcU2fg1hC3fBT9Q3bkLznxb8l1wIYKBWLh-h09H7z8P9oDWLCExMeR1oqrnVWhQm14RwbTkTYS6USfOEq0jxvAgNyJ4WtkhDbZlSoXG1olUssglV9DFaK6elfYqwEIoUuSBEK_DjFpolOky5gR59YTnpoVcdUuSs0QSRvpYiXDpwSQ8uGfIe2uxgJFU1kd_NRMapFNLBzQ2ydQlYFyMRlzQyymkPbXdIky7koY-jSjtdVDKFaGIk7aEnDe7-zaLFcg-xS4i8uADExC-fcTjzouItrjavfec2Wj_eG8mPB0cfnqE7Ha0mjJ6jtXq-sC9c7lbrLR-lfwHrcURj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+Species+Distribution+and+Susceptibility+of+Bloodstream+Isolates+of+Candida+Collected+in+Monterrey%2C+Mexico%2C+to+Seven+Antifungal+Agents+%3A+Results+of+a+3-Year+%282004+to+2007%29+Surveillance+Study&rft.jtitle=Journal+of+clinical+microbiology&rft.au=GONZALEZ%2C+Gloria+M&rft.au=ELIZONDO%2C+Mariana&rft.au=AYALA%2C+Jacobo&rft.date=2008-09-01&rft.pub=American+Society+for+Microbiology&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=46&rft.issue=9&rft.spage=2902&rft.epage=2905&rft_id=info:doi/10.1128%2FJCM.00937-08&rft.externalDBID=n%2Fa&rft.externalDocID=20637383
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon